These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2579873)

  • 21. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
    Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
    Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
    Wada Y; Satoh K; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
    Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia.
    Spedding M; DiFrancesco GF; Mir AK; Petty MA; Berg C; Gittos M
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):62-71. PubMed ID: 2441155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.
    Hof RP; Hof A; Scholtysik G; Menninger K
    J Cardiovasc Pharmacol; 1984; 6(3):407-16. PubMed ID: 6202965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
    Tejerina MT; Delgado C; Diez J; Tamargo J
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):64-80. PubMed ID: 6497511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.